BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 30170320)

  • 1. Structure-activity relationship studies of lipophilic teicoplanin pseudoaglycon derivatives as new anti-influenza virus agents.
    Szűcs Z; Kelemen V; Le Thai S; Csávás M; Rőth E; Batta G; Stevaert A; Vanderlinden E; Naesens L; Herczegh P; Borbás A
    Eur J Med Chem; 2018 Sep; 157():1017-1030. PubMed ID: 30170320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Semisynthetic teicoplanin derivatives as new influenza virus binding inhibitors: synthesis and antiviral studies.
    Bereczki I; Kicsák M; Dobray L; Borbás A; Batta G; Kéki S; Nikodém ÉN; Ostorházi E; Rozgonyi F; Vanderlinden E; Naesens L; Herczegh P
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3251-4. PubMed ID: 24974341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of isoindole and benzoisoindole derivatives of teicoplanin pseudoaglycon with remarkable antibacterial and antiviral activities.
    Sipos A; Török Z; Rőth E; Kiss-Szikszai A; Batta G; Bereczki I; Fejes Z; Borbás A; Ostorházi E; Rozgonyi F; Naesens L; Herczegh P
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7092-6. PubMed ID: 23099097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of Antiviral Perfluoroalkyl Derivatives of Teicoplanin and Vancomycin.
    Bereczki I; Csávás M; Szűcs Z; Rőth E; Batta G; Ostorházi E; Naesens L; Borbás A; Herczegh P
    ChemMedChem; 2020 Sep; 15(17):1661-1671. PubMed ID: 32652783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and biological evaluation of lipophilic teicoplanin pseudoaglycon derivatives containing a substituted triazole function.
    Szűcs Z; Csávás M; Rőth E; Borbás A; Batta G; Perret F; Ostorházi E; Szatmári R; Vanderlinden E; Naesens L; Herczegh P
    J Antibiot (Tokyo); 2017 Feb; 70(2):152-157. PubMed ID: 27353163
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipophilic teicoplanin pseudoaglycon derivatives are active against vancomycin- and teicoplanin-resistant enterococci.
    Szűcs Z; Bereczki I; Csávás M; Rőth E; Borbás A; Batta G; Ostorházi E; Szatmári R; Herczegh P
    J Antibiot (Tokyo); 2017 May; 70(5):664-670. PubMed ID: 28144040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diazo transfer-click reaction route to new, lipophilic teicoplanin and ristocetin aglycon derivatives with high antibacterial and anti-influenza virus activity: an aggregation and receptor binding study.
    Pintér G; Batta G; Kéki S; Mándi A; Komáromi I; Takács-Novák K; Sztaricskai F; Röth E; Ostorházi E; Rozgonyi F; Naesens L; Herczegh P
    J Med Chem; 2009 Oct; 52(19):6053-61. PubMed ID: 19791806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A few atoms make the difference: synthetic, CD, NMR and computational studies on antiviral and antibacterial activities of glycopeptide antibiotic aglycon derivatives.
    Bereczki I; Mándi A; Rőth E; Borbás A; Fizil Á; Komáromi I; Sipos A; Kurtán T; Batta G; Ostorházi E; Rozgonyi F; Vanderlinden E; Naesens L; Sztaricskai F; Herczegh P
    Eur J Med Chem; 2015 Apr; 94():73-86. PubMed ID: 25752526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and antibacterial evaluation of some teicoplanin pseudoaglycon derivatives containing alkyl- and arylthiosubstituted maleimides.
    Csávás M; Miskovics A; Szűcs Z; Rőth E; Nagy ZL; Bereczki I; Herczeg M; Batta G; Nemes-Nikodém É; Ostorházi E; Rozgonyi F; Borbás A; Herczegh P
    J Antibiot (Tokyo); 2015 Sep; 68(9):579-85. PubMed ID: 25829202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of dihydrofuran-fused perhydrophenanthrenes as a new anti-influenza agent having novel structural characteristic.
    Matsuya Y; Sasaki K; Ochiai H; Nemoto H
    Bioorg Med Chem; 2007 Jan; 15(1):424-32. PubMed ID: 17035034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent activity of isopulegol-derived substituted octahydro-2H-chromen-4-ols against influenza A and B viruses.
    Ilyina IV; Zarubaev VV; Lavrentieva IN; Shtro AA; Esaulkova IL; Korchagina DV; Borisevich SS; Volcho KP; Salakhutdinov NF
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2061-2067. PubMed ID: 29716780
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New semisynthetic teicoplanin derivatives have comparable in vitro activity to that of oritavancin against clinical isolates of VRE.
    Szűcs Z; Ostorházi E; Kicsák M; Nagy L; Borbás A; Herczegh P
    J Antibiot (Tokyo); 2019 Jul; 72(7):524-534. PubMed ID: 30874609
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New semisynthetic glycopeptides MDL 63,246 and MDL 63,042, and other amide derivatives of antibiotic A-40,926 active against highly glycopeptide-resistant VanA enterococci.
    Malabarba A; Ciabatti R; Scotti R; Goldstein BP; Ferrari P; Kurz M; Andreini BP; Denaro M
    J Antibiot (Tokyo); 1995 Aug; 48(8):869-83. PubMed ID: 7592033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and antibacterial activity of alkyl derivatives of the glycopeptide antibiotic A40926 and their amides.
    Maffioli SI; Ciabatti R; Romanò G; Marzorati E; Preobrazhenskaya M; Pavlov A
    Bioorg Med Chem Lett; 2005 Aug; 15(16):3801-5. PubMed ID: 15993054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives.
    Selvam P; Murugesh N; Chandramohan M; Sidwell RW; Wandersee MK; Smee DF
    Antivir Chem Chemother; 2006; 17(5):269-74. PubMed ID: 17176631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery of dihydro-alkyloxy-benzyl-oxopyrimidines as promising anti-influenza virus agents.
    Yu M; Liu A; Du G; Naesens L; Vanderlinden E; De Clercq E; Liu X
    Chem Biol Drug Des; 2011 Oct; 78(4):596-602. PubMed ID: 21752202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo.
    Zarubaev VV; Garshinina AV; Tretiak TS; Fedorova VA; Shtro AA; Sokolova AS; Yarovaya OI; Salakhutdinov NF
    Antiviral Res; 2015 Aug; 120():126-33. PubMed ID: 26072310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-influenza drug discovery: structure-activity relationship and mechanistic insight into novel angelicin derivatives.
    Yeh JY; Coumar MS; Horng JT; Shiao HY; Kuo FM; Lee HL; Chen IC; Chang CW; Tang WF; Tseng SN; Chen CJ; Shih SR; Hsu JT; Liao CC; Chao YS; Hsieh HP
    J Med Chem; 2010 Feb; 53(4):1519-33. PubMed ID: 20092255
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
    Zarubaev VV; Golod EL; Anfimov PM; Shtro AA; Saraev VV; Gavrilov AS; Logvinov AV; Kiselev OI
    Bioorg Med Chem; 2010 Jan; 18(2):839-48. PubMed ID: 20006516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anti-influenza virus activity of 4-guanidino-7-substituted Neu5Ac2en derivatives.
    Honda T; Masuda T; Yoshida S; Arai M; Kobayashi Y; Yamashita M
    Bioorg Med Chem Lett; 2002 Aug; 12(15):1921-4. PubMed ID: 12113809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.